C.M. Bidwell & Associates’s Insulet PODD Stock Holding History

C.M. Bidwell & Associates’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$242K	Sell	1,152 -3	-0.3%	-$754	0.11%	119
2025 Q4	$328K	Sell	1,155 -34	-3%	-$10.6K	0.16%	82
2025 Q3	$367K	Sell	1,189 -55	-4%	-$17.2K	0.18%	78
2025 Q2	$391K	Sell	1,244 -62	-5%	-$17.9K	0.2%	76
2025 Q1	$343K	Sell	1,306 -23	-2%	-$6.22K	0.21%	82
2024 Q4	$347K	Sell	1,329 -45	-3%	-$11.3K	0.21%	80
2024 Q3	$320K	Buy	1,374 +295	+27%	+$60.6K	0.2%	81
2024 Q2	$218K	Sell	1,079 -709	-40%	-$128K	0.15%	109
2024 Q1	$306K	Buy	1,788 +1	+0.1%	+$186	0.21%	85
2023 Q4	$388K	Buy	1,787 +1,130	+172%	+$194K	0.29%	67
2023 Q3	$105K	Sell	657 -142	-18%	-$31.8K	0.08%	221
2023 Q2	$230K	Buy	799 +458	+134%	+$139K	0.17%	110
2023 Q1	$109K	Buy	+341	New	+$101K	0.08%	219
2018 Q1	–	Sell	-2,730	Closed	-$188K	–	429
2017 Q4	$188K	Buy	+2,730	New	+$179K	0.16%	176

Other funds holding PODD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

C.M. Bidwell & Associates's PODD Position: Q1 2026 in Review

C.M. Bidwell & Associates reduced its Insulet (PODD) stake by 0.26% in Q1 2026, selling an estimated $754 and leaving 1,152 shares worth $242K. The position accounts for 0.11% of the portfolio, ranked #119.

C.M. Bidwell & Associates first reported a position in PODD in Q4 2017 and has held it in 14 quarters since. The position peaked at $391K in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

C.M. Bidwell & Associates held 1,152 shares of Insulet worth $242K as of Q1 2026.
C.M. Bidwell & Associates sold 3 Insulet shares in Q1 2026, an estimated $754.
Insulet made up 0.11% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #119 holding.
C.M. Bidwell & Associates first reported a position in Insulet in Q4 2017 and has held it in 14 quarters since.
C.M. Bidwell & Associates's Insulet position peaked at $391K in Q2 2025.
784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.